Activated phosphoinositide 3-kinase (PI3K)-AKT signaling appears to be an obligate event in the development of cancer. The highly related members of the mammalian FoxO transcription factor family, FoxO1, FoxO3, and FoxO4, represent one of several effector arms of PI3K-AKT signaling, prompting genetic analysis of the role of FoxOs in the neoplastic phenotypes linked to PI3K-AKT activation. While germline or somatic deletion of up to five FoxO alleles produced remarkably modest neoplastic phenotypes, broad somatic deletion of all FoxOs engendered a progressive cancer-prone condition characterized by thymic lymphomas and hemangiomas, demonstrating that the mammalian FoxOs are indeed bona fide tumor suppressors. Transcriptome and promoter analyses of differentially affected endothelium identified direct FoxO targets and revealed that FoxO regulation of these targets in vivo is highly context-specific, even in the same cell type. Functional studies validated Sprouty2 and PBX1, among others, as FoxO-regulated mediators of endothelial cell morphogenesis and vascular homeostasis.
Pubmed ID: 17254969 RIS Download
Mesh terms: Animals | Cell Differentiation | Cell Lineage | Cell Transformation, Neoplastic | Drosophila Proteins | Endothelial Cells | Forkhead Box Protein O1 | Forkhead Box Protein O3 | Forkhead Transcription Factors | Gene Expression Regulation, Neoplastic | Hemangioma | Homeodomain Proteins | Homeostasis | Lymphoma | Mice | Mice, Knockout | Neovascularization, Physiologic | Nerve Tissue Proteins | Phosphatidylinositol 3-Kinases | Proto-Oncogene Proteins c-akt | Signal Transduction | Transcription Factors | Tumor Suppressor Proteins
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.